Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral

Psychological Medicine

Volumn 41, Issue 5, 2011, Pages 983-995

  Tsaltas, E ^a   Kalogerakou, S ^a   Papakosta, V M ^a   Kontis, D ^a,b   Theochari, E ^b   Koutroumpi, M ^a   Anyfandi, E ^a   Michopoulos, I ^c   Poulopoulou, C ^a   Papadimitriou, G ^b   Oulis, P ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Psychiatric Hospital of Attika Dafni   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

CANTAB; electroconvulsive therapy; executive function; major depression; visuospatial memory

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; EXECUTIVE FUNCTION; FEMALE; GREECE; HUMAN; MAJOR DEPRESSION; MEMORY DISORDER; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; STATISTICAL ANALYSIS; TREATMENT FAILURE;

ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; EXECUTIVE FUNCTION; FEMALE; GREECE; HUMANS; MATCHED-PAIR ANALYSIS; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TREATMENT FAILURE;

EID: 79960312266     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710001443     Document Type: Article

References (84)

1. APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. American Psychiatric Association : Washington, DC.
2. APA (2001). The Practice of Electroconvulsive Therapy : Recommendations for Treatment, Training, and Privileging. American Psychiatric Association : Washington, DC.
3. Barnett JH, Sahakian BJ, Werners U, Hill KE, Brazil R, Gallagher O, Bullmore ET, Jones PB (2005). Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychological Medicine 35, 1031-1041. (Pubitemid 41015701)
4. Berlim MT, Turecki G (2007). What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. European Neuropsychopharmacology 17, 696-707. (Pubitemid 47422400)
5. Biringer E, Lundervold A, Stordal K, Mykletun A, Egeland J, Bottlender R, Lund A (2005). Executive function improvement upon remission of recurrent unipolar depression. European Archives of Psychiatry and Clinical Neuroscience 255, 373-380. (Pubitemid 43029826)
6. Brittlebank AD, Scott J, Williams JM, Ferrier IN (1993). Autobiographical memory in depression : state or trait marker? British Journal of Psychiatry 162, 118-121. (Pubitemid 23017024)
7. Burke JG, Patel JKM, Morris PK, Reveley MA (1998). Risperidone improves antisaccade error rates in schizophrenia. Schizophrenia Research 29, 115.
8. Cassano GB, Puca F, Scapicchio PL, Trabucchi M (2002). Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. Journal of Clinical Psychiatry 63, 396-402. (Pubitemid 34507216)
9. Chen CH, Suckling J, Ooi C, Fu CH, Williams SC, Walsh ND, Mitterschiffthaler MT, Pich EM, Bullmore E (2008). Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 33, 1909-1918. (Pubitemid 351832606)
10. Christensen H, Griffiths K, Mackinnon A, Jacomb P (1997). A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. Journal of the International Neuropsychological Society 3, 631-651. (Pubitemid 27510846)
11. Clark L, Chamberlain SR, Sahakian BJ (2009). Neurocognitive mechanisms in depression : implications for treatment. Annual Review of Neuroscience 32, 57-74.
12. Clark L, Sarna A, Goodwin GM (2005). Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression. American Journal of Psychiatry 162, 1980-1982. (Pubitemid 41428635)
13. Cuesta MJ, Peralta V, Zarzuela A (2001). Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia : a longitudinal study. Schizophrenia Research 48, 17-28. (Pubitemid 32241180)
14. Elliott R, Sahakian BJ, Herrod JJ, Robbins TW, Paykel ES (1997). Abnormal response to negative feedback in unipolar depression : evidence for a diagnosis specific impairment. Journal of Neurology, Neurosurgery and Psychiatry 63, 74-82. (Pubitemid 27317364)
15. Elliott R, Sahakian BJ, McKay AP, Herrod JJ, Robbins TW, Paykel ES (1996). Neuropsychological impairments in unipolar depression : the influence of perceived failure on subsequent performance. Psychological Medicine 26, 975-989. (Pubitemid 26305998)
16. Falconer DW, Cleland J, Fielding S, Reid IC (2010). Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory. Psychological Medicine 40, 1017-1025.
17. First M, Spitzer R, Gibbon M, Williams J (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). Biometrics Research Department, New York State Psychiatric Institute : New York.
18. Folstein MF, Folstein SE, McHugh PR (1975). Mini-mental state . A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
19. Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ (1997). Computerised neuropsychological tests in the early detection of dementia: prospective findings. Journal of the International Neuropsychological Society 3, 139-146. (Pubitemid 27168262)
20. Frasch K, Bullacher C, Jäger M, Kilian R, Rink M, Wittek R, Becker T, Neumann NU (2009). Effects of symptom reduction and psychotropic medication on cognitive impairment in depression. Psychopathology 42, 59-66.
21. Furlan PM, Kallan MJ, Ten Have T, Pollock BG, Katz I, Lucki I (2001). Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. Journal of Geriatric Psychiatry 9, 429-438. (Pubitemid 33015131)
22. Goldstein SG, Filskov SB, Weaver LA (1977). Neuropsychological effects of electroconvulsive therapy. Journal of Clinical Psychiatry 33, 798-806. (Pubitemid 8251251)
23. Gualtieri CT, Johnson LG (2007). Bupropion normalizes cognitive performance in patients with depression. Medscape General Medicine 9, 22.
24. Halliday AM, Davidson K, Browne MW, Kreeger LC (1968). A comparison of the effects on depression and memory of bilateral ECT and unilateral ECT to the dominant and non-dominant hemispheres. British Journal of Psychiatry 114, 997-1012.
25. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
26. Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Guzmán D, Guàrdia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE (2009). Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. Journal of Psychiatric Research 43, 855-863.
27. Johnstone T, van Reekum CM, Urry HL, Kalin NH, Davidson RJ (2007). Failure to regulate : counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. Journal of Neuroscience 27, 8877-8884. (Pubitemid 47292771)
28. Joyce PR, Paykel ES (1989). Predictors of drug response in depression. Archives of General Psychiatry 46, 89-99. (Pubitemid 19038412)
29. Keefe RSE, Young CA, Rock SL, Purdon SE, Gold JM, Breier A (2006). One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophrenia Research 81, 1-15.
30. Konarski JZ, Kennedy SH, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS (2009). Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry and Neuroscience 34, 175-180.
31. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW (1995). Comparison of executive and visuospatial memory function in Huntingtons disease and dementia of Alzheimers type matched for degree of dementia. Journal of Neurology, Neurosurgery and Psychiatry 58, 598-606.
32. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, Ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ (1998). Evidence for specific cognitive deficits in preclinical Huntingtons disease. Brain 121, 1329-1341. (Pubitemid 28327409)
33. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996). Executive and mnemonic functions in early Huntingtons disease. Brain 119, 1633-1645. (Pubitemid 26375733)
34. Lembke A, Ketter TA (2002). Impaired recognition of facial emotion in mania. American Journal of Psychiatry 159, 302-304. (Pubitemid 34126910)
35. Lerer B, Shapira B, Calev A, Tubi N, Drexler H, Kindler S, Lidsky D, Schwartz JE (1995). Antidepressant and cognitive effects of twice vs. three times weekly ECT. American Journal of Psychiatry 152, 564-570.
36. Li CT, Lin CP, Chou KH, Chen IY, Hsieh JC, Wu CL, Lin WC, Su TP (2010). Structural and cognitive deficits in remitting and non-remitting recurrent depression : a voxel-based morphometric study. NeuroImage 50, 347-356.
37. Mayberg HS (2003). Modulating dysfunctional limbiccortical circuits in depression : towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 65, 193-207. (Pubitemid 36406467)
38. McCall WV, Dunn A, Rosenquist PB (2004). Quality of life and function after ECT. British Journal of Psychiatry 185, 405-409.
39. McGurk SR, Lee MA, Jayathilake K, Meltzer HY (2004). Cognitive effects of olanzapine treatment in schizophrenia. Medscape General Medicine 6, 27.
40. Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW (1999). Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinsons disease. Psychopharmacology (Berlin) 146, 162-174. (Pubitemid 29474208)
41. Meyer-Lindberg A, Gruppe H, Bauer U, Lis S, Krieger S, Galhoffer B (1997). Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine : results from a double-blind study. Pharmacopsychiatry 30, 35-42. (Pubitemid 27158038)
42. Mishara AL, Goldberg TE (2004). A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia : opening a closed book. Biological Psychiatry 55, 1013-1022. (Pubitemid 38581917)
43. Miyashita Y, Kameyama M, Hasegawa I, Fukushima T (1998). Consolidation of visual associative long-term memory in the temporal cortex of primates. Neurobiology of Learning and Memory 70, 197-211. (Pubitemid 28455592)
44. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999). Emotional bias and inhibitory control processes in mania and depression. Psychological Medicine 29, 1307-1321.
45. Nakano Y, Baba H, Maeshima H, Kitajima A, Sakai Y, Baba K, Suzuki T, Mimura M, Arai H (2008). Executive dysfunction in medicated, remitted state of major depression. Journal of Affective Disorders 111, 46-51.
46. Neu P, Kiesslinger U, Schlattmann P, Reischies FM (2001). Time-related cognitive deficiency in four different types of depression. Psychiatry Research 103, 237-247. (Pubitemid 32817083)
47. Ng C, Schweitzer I, Alexopoulos P, Celi E, Wong L, Tuckwell V, Sergejew A, Tiller J (2000). Efficacy and cognitive effects of right unilateral electroconvulsive therapy. Journal of ECT 16, 370-379.
48. OGrada C, Dinan T (2007). Executive function in schizophrenia : what impact do antipsychotics have? Human Psychopharmacology : Clinical and Experimental 22, 397-406. (Pubitemid 47316124)
49. Olver JS, Ignatiadis S, Maruff P, Burrows GD, Norman TR (2008). Quetiapine augmentation in depressed patients with partial response to antidepressants. Human Psychopharmacology 23, 653-660.
50. Owen AM, Iddon JL, Hodges JR, Summers BA, Robbins TW (1997). Spatial and non-spatial working memory at different stages of Parkinsons disease. Neuropsychologia 35, 519-532. (Pubitemid 27144004)
51. Owen AM, Morris RG, Sahakian BJ, Polkey CE, Robbins TW (1996). Double dissociations of memory and executive functions in working memory task following frontal lobe excisions, temporal lobe excisions, or amygdalohippocampectomy in man. Brain 119, 1597-1615. (Pubitemid 26375730)
52. Owen AM, Roberts AC, Hodges JR, Summers BA, Polkey CE, Robbins TW (1993). Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinsons disease. Brain 116, 1159-1175. (Pubitemid 23329887)
53. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW (1991). Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 29, 993-1006.
54. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW (1995). Visuo-spatial short-term recognition memory and learning after temporal lobe excision, frontal lobe excision or amygdalo-hyppocampectomy in man. Neuropsychologia 33, 1-24.
55. Paelecke-Habermann Y, Pohl J, Leplow B (2005). Attention and executive functions in remitted major depression patients. Journal of Affective Disorders 89, 125-135. (Pubitemid 41740840)
56. Papakostas GI, Fava M, Thase ME (2008). Treatment of SSRI-resistant depression : a meta-analysis comparing within- versus across-class switches. Biological Psychiatry 63, 699-704. (Pubitemid 351329277)
57. Porter RJ, Bourke C, Gallagher P (2007). Neuropsychological impairment in major depression : its nature, origin and clinical significance Australian and New Zealand Journal of Psychiatry 41, 115-128. (Pubitemid 46705623)
58. Porter RJ, Gallagher P, Thompson JM, Young AH (2003). Neurocognitive impairment in drug-free patients with major depressive disorder. British Journal of Psychiatry 182, 214-220. (Pubitemid 36286734)
59. Postma A, Jager G, Kessels RP, Koppeschaar HP, van Honk J (2004). Sex differences for selective forms of spatial memory. Brain and Cognition 54, 24-34. (Pubitemid 38084774)
60. Purcell R, Maruff P, Kyrios M, Pantelis C (1997). Neuropsychological function in young patients with unipolar major depression. Psychological Medicine 27, 1277-1285. (Pubitemid 27494093)
61. Rahman S, Robbins TW, Sahakian BJ (1999). Comparative cognitive neuropsychological studies of frontal lobe function : implications for therapeutic strategies in frontal variant frontotemporal dementia. Dementia and Geriatric Cognitive Disorders 10, 15-28. (Pubitemid 29348609)
62. Rami-Gonzajez L, Bernardo M, Boget T, Gil-Verona JA, Salamero M, Junque C (2001). Subtypes of memory dysfunction associated with ECT: characteristics and neurobiological bases. Journal of ECT 17, 129-135. (Pubitemid 32545784)
63. Reischies FM, Neu P (2000). Comorbidity of mild cognitive disorder and depression - a neuropsychological analysis. European Archives of Psychiatry and Clinical Neuroscience 250, 186-193. (Pubitemid 30664277)
64. Rey A (1964). Lexamen clinique en psychologie. Presses Universitaires de France : Paris.
65. Riedel WJ, Eikmans K, Heldens A, Schmitt JA (2005). Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. Journal of Psychopharmacology 19, 12-20.
66. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study in a large number of normal elderly volunteers. Dementia 5, 266-281. (Pubitemid 24231105)
67. Robertson H, Pryor R (2006). Memory and cognitive effects of ECT: informing and assessing patients. Advances in Psychiatric Treatment 12, 228-238.
68. Rogers RD, Andrews TC, Grasby PM, Brooks DJ, Robbins TW (2000). Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. Journal of Cognitive Neuroscience 12, 142-162. (Pubitemid 30142790)
69. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006). Acute and longer term outcomes in depressed outpatients requiring one or several treatment steps : a STAR*D report. American Journal of Psychiatry 163, 1905-1917. (Pubitemid 44807782)
70. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000). A prospective, randomised, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Archives of General Psychiatry 57, 425-433.
71. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M (2007). The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 32, 244-254. (Pubitemid 44967804)
72. Sahakian BJ, Downes JJ, Eagger S, Evenden JL, Levy R, Philpot MP, Roberts AC, Robbins TW (1990). Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimers type. Neuropsychologia 28, 1197-1213.
73. Sahgal A, Sahakian BJ, Robbins TW, Wray CJ, Lloyd S, Cook JH, McKeith IG, Disley JCA, Eagger S, Boddington S, Edwardson JA (1991). Detection of visual memory and learning deficits in Alzheimers disease using the Cambridge Neuropsychological Test Automated Battery. Dementia 2, 150-158.
74. Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME (2007). Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression : related and independent features. Biological Psychiatry 61, 198-209. (Pubitemid 46072788)
75. Smith ML, Milner B (1981). The role of the right hippocampus in the recall of spatial location. Neuropsychologia 19, 781-793. (Pubitemid 12251245)
76. Squire LR, Wetzel CD, Slater PC (1979). Memory complaints after electroconvulsive therapy: assessment with a new self-rating instrument. Biological Psychiatry 14, 791-801. (Pubitemid 10215218)
77. Steffens DC, Welsh-Bohmer KA, Burke JR, Plassman BL, Beyer JL, Gersing KR, Potter GG (2004). Methodology and preliminary results from the Neurocognitive Outcomes of Depression in the Elderly study. Journal of Geriatric Psychiatry and Neurology 17, 202-211. (Pubitemid 40515139)
78. Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD, Iddon JL, Robbins TW, Sahakian BJ (2001). Early detection and differential diagnosis of Alzheimers disease and depression with neuropsychological tasks. Dementia and Geriatric Cognitive Disorders 12, 265-280. (Pubitemid 32429726)
79. Tyson PJ, Laws KR, Roberts KH, Mortimer AM (2004). Stability of set-shifting and planning abilities in patients with schizophrenia. Psychiatry Research 129, 229-239. (Pubitemid 40127535)
80. UK ECT Review Group (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders : a systematic review and meta-analysis. Lancet 361, 799-808.
81. Velligan DI, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL (2002). Does cognitive function improve with quetiapine in comparison to haloperidol ? Schizophrenia Research 15, 239-248. (Pubitemid 34008588)
82. Wager TD, Phan KL, Liberzon I, Taylor SF (2003). Valence, gender, and lateralization of functional brain anatomy in emotion: a meta-analysis of findings from neuroimaging. NeuroImage 19, 513-531. (Pubitemid 36926274)
83. Wood SJ, Proffitt T, Mahony K, Smith DJ, Buchanan JA, Brewer W, Stuart GW, Velakoulis D, McGorry PD, Pantelis C (2002). Visuospatial memory and learning in first episode schizophreniform psychosis and established schizophrenia : a functional correlate of hippocampal pathology? Psychological Medicine 32, 429-438. (Pubitemid 34308787)
84. Woodward ND, Purdon SE, Meltzer HY, Zald DH (2005). A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. International Journal of Neuropsychopharmacology 8, 457-472. (Pubitemid 41002500)